The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting
Top Cited Papers
- 1 May 2001
- journal article
- review article
- Published by Elsevier in Advances in Enzyme Regulation
- Vol. 41 (1), 189-207
- https://doi.org/10.1016/s0065-2571(00)00013-3
Abstract
No abstract availableFunding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 43 references indexed in Scilit:
- Tumor-selective Blood Flow Decrease Induced by an Angiotensin Converting Enzyme Inhibitor, Temocapril HydrochlorideJapanese Journal of Cancer Research, 2000
- Drug Targeting in Cancer Therapy: The Magic Bullet, What Next?Journal of Drug Targeting, 1996
- Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrierEuropean Journal Of Cancer, 1995
- Targeting chemotherapy for hepatoma: Arterial administration of anticancer drugs dissolved in lipiodolEuropean Journal Of Cancer, 1992
- Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cellsBiochemical and Biophysical Research Communications, 1989
- Image enhancement in computerized tomography for sensitive diagnosis of liver cancer and semiquantitation of tumor selective drug targeting with oily contrast mediumCancer, 1985
- Selective targeting of anti-cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast mediumCancer, 1984
- Tailor-making of protein drugs by polymer conjugation for tumor targeting: A brief review on smancsProtein Journal, 1984
- Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary reportEuropean Journal of Cancer and Clinical Oncology, 1983
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971